A carregar...

Host MyD88 signaling protects against acute graft‐versus‐host disease after allogeneic bone marrow transplantation

Recent experimental strategies to reduce graft‐versus‐host disease (GVHD) have focused largely on modifying innate immunity. Toll‐like receptor (TLR)‐driven myeloid differentiation primary response 88 (MyD88)‐dependent signalling pathways that initiate adaptive immune function are also critical for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Exp Immunol
Main Authors: Xing, S., Zhang, X., Liu, J. H., Huang, X., Zhou, P.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300651/
https://ncbi.nlm.nih.gov/pubmed/30317551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13215
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!